BMC Women s Health, Journal Year: 2024, Volume and Issue: 24(1)
Published: Sept. 19, 2024
Language: Английский
BMJ Sexual & Reproductive Health, Journal Year: 2024, Volume and Issue: 50(3), P. 212 - 225
Published: June 10, 2024
Menstrual health is a key patient-reported outcome beyond its importance as general indicator of and fertility. However, menstrual function was not measured in the clinical trials COVID-19 vaccines. The purpose this review to synthesise existing literature on relationship between vaccination outcomes.
Language: Английский
Citations
9
Frontiers in Drug Safety and Regulation, Journal Year: 2024, Volume and Issue: 4
Published: Jan. 31, 2024
Introduction: Menstrual disorders are commonly reported after COVID-19 vaccination and heavy menstrual bleeding was added to the product information of vaccines Moderna Pfizer. The aim this review, using a systematic search, is provide an overview available literature on risk vaccination. Methods: review conducted according Preferred Reporting Items for Systematic reviews Meta-Analysis (PRISMA) guidelines. A PubMed search performed 15 August 2023, including solely quantitative studies in English Dutch. Results: total 61 were included, which 40 cross-sectional studies, 18 cohort three self-controlled case series. Outcomes included wide variety disorders, changes cycle length ( n = 54), amount 44), menses 30), experience (pre)menstrual pain 21), breakthrough 18). All found higher percentage at least one disorder first different types doses. Discussion: In conclusion, evidence suggests that may cause women reproductive age. However, there need more longitudinal because important limitations study designs many studies. Although short-lived predominantly mild, it healthcare professionals be informed about these potential adverse reactions assess events clinical trials vaccines.
Language: Английский
Citations
7
Women & Health, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 15
Published: Jan. 17, 2025
A growing body of evidence suggests a potential link between the SARS-CoV-2 vaccine and menstrual changes in women who were menstruating at time vaccination. Nevertheless, prevalence this event those with secondary amenorrhea for different causes, i.e. formerly women, remains unclear. It is plausible that, analogous to observed currently they experienced some degree alteration their reproductive health, defined here as menstrual-related disturbances. The aim was analyze phenomenon identify factors associated occurrence disturbances subpopulation. Study design: retrospective observational cross-sectional study conducted among adult Spanish December 2021 using an online survey (N = 17,512). present analysis includes subpopulation vaccinated 548). General characteristics, medical history, adverse events following COVID-19 vaccination recorded. Chi-square, Mann-Whitney U McNemar mid-P tests performed. Bivariate logistic regression then used key influencing unexpected event. In comparison first dose, significantly higher percentages respondents (dose 1: 38.5 percent vs. dose 2: 44.8 percent) after receiving second one. Among them, related length flow stand out, being long-term nature about 17-20 cases. Interindividual 1 may include weight, perimenopause, preexisting diagnoses non-autoimmune rheumatic/articular conditions, use hormonal contraceptives, suffering from other side effects - such arm pain number previous pregnancies; 2, these alterations 1, well contraceptives perimenopause. Formerly might experience Potential pregnancies.
Language: Английский
Citations
0
European Journal of Epidemiology, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 7, 2025
Abstract BiCoVac is a population-based Danish cohort aiming to examine whether Coronavirus disease 2019 (COVID-19) vaccines are associated with non-specific symptoms beyond the specific protection of COVID-19. Data were collected by four questionnaire surveys between May 2021 and July 2022 distribution was aligned COVID-19 vaccination program. All self-reported information on (e.g., headache, nausea, fatigue). The baseline survey additionally gathered lifestyle health. Survey data combined from registers including test results. A total 911,613 (25% all citizens aged 16 65) randomly sampled for 252,401 initiated questionnaire. Of these, 59% ( n = 149,070) participated in 1st follow-up, 43% 107,655) 2nd 25% 63,737) 3rd follow-up. Women individuals above 40 years age more likely participate. Among vaccinated respondents, 25–38% reported moderate severe immediate following vaccination, varying vaccine doses. Females, younger individuals, those prior symptoms. Results potential did not reveal higher risk involuntary movements among compared unvaccinated individuals. Currently (December 2024), we further investigating effects other exploring characteristics render some susceptible report In addition, long-term being investigated.
Language: Английский
Citations
0
Pharmacoepidemiology and Drug Safety, Journal Year: 2024, Volume and Issue: 33(8)
Published: Aug. 1, 2024
ABSTRACT Background Reports of adverse menstrual events emerged during the COVID‐19 vaccination campaign in multiple countries. This raised question whether these reports were caused by vaccines. The aim this systematic review was to evaluate comparative studies on topic (registered at PROSPERO [CRD42022324973]). Methods We included observational such as cohort and surveys comparing response self‐reported questionnaires between post‐ versus pre‐vaccination data. PubMed Cochrane Library searches conducted 1 September 2023. primary outcome incidence any prespecified event, measure risk ratio. meta‐analysis using Mantel–Haenszel method random effects model. summarized results factors well key findings included. Results retrieved 161 references from electronic databases additional sources lists. Of those, we considered 21 studies. event reported 12 resulted a pooled estimate (risk ratio 1.13; 95% CI, 0.96–1.31) that did not favor group. analysis constrained considerable clinical statistical heterogeneity. Risk for changes history infection, concern about vaccines, smoking, previous cycle irregularities, depression, stress, other issues. Conclusions group heterogeneity prevalent among Most suggested temporary, minor, nonserious.
Language: Английский
Citations
2
BMC Women s Health, Journal Year: 2024, Volume and Issue: 24(1)
Published: Sept. 19, 2024
Language: Английский
Citations
1